IGF1 and obstructive sleep apnea syndrome: First, our findings imply that serum/plasma IGF-1 concentrations may be a possible biological biomarker for measuring OSAHS severity, which may assist clinicians in accurately diagnosing OSAHS and determining the disease severity.